Conference
PCN58 A COST UTILITY ANALYSIS OF ERLOTINIB IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC)
Authors
Bradbury P; Jang R; Isogai P; Ng R; Mittmann N; Evans W; Shepherd F; Leighl N
Volume
11
Publisher
Elsevier
Publication Date
5 2008
DOI
10.1016/s1098-3015(10)70236-9
Conference proceedings
Value in Health
Issue
3
ISSN
1098-3015